glp 1 and general anesthesia Perioperative management of patients taking glucagon-like peptide receptor agonists: Society for Perioperative Assessment Quality Improvement (SPAQI) multidisciplinary consensus statement Anesthetic Considerations for Patients Taking

One of the biggest challenges of the CCl 4 model for induction of experimental liver cirrhosis is the high mortality rate in animals, increasing cost, and animal suffering (Regimbeau et al., 2008

Some researchers have pointed out that the common digestive adverse reactions of the drug (diarrhea, vomiting, loss of appetite) may be contributing to their supposed weight loss success and are not ideal ways to support metabolic health at its foundation

Not every patient responds equally

A thorough assessment helps differentiate between medication-related effects, underlying cardiac conditions, and benign sensations that require only reassurance

Reference Tuell JL, Bhattacharya D, Leeuwenburgh C, Chaudhuri A, Kumar V